GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2021-08-11 $46.28 $46.28 $42.21 $43.26 741 741
2021-08-10 $45.63 $46.74 $44.28 $46.50 505 482
2021-08-09 $47.69 $48.02 $46.70 $46.86 485 348
2021-08-06 $48.05 $48.14 $44.03 $47.60 550 066
2021-08-05 $44.97 $48.14 $44.18 $47.70 1 310 252
2021-08-04 $44.20 $45.65 $43.70 $44.84 878 197
2021-08-03 $43.69 $45.05 $43.22 $44.89 388 141
2021-08-02 $43.75 $44.89 $43.02 $43.70 733 137
2021-07-30 $43.90 $45.16 $43.64 $43.75 336 178
2021-07-29 $44.70 $45.65 $43.73 $44.16 881 461
2021-07-28 $41.58 $44.78 $41.58 $44.52 682 639
2021-07-27 $42.96 $42.96 $41.33 $41.63 464 914
2021-07-26 $42.93 $44.33 $41.74 $43.38 408 312
2021-07-23 $44.18 $44.91 $41.88 $42.60 837 336
2021-07-22 $44.85 $44.96 $43.65 $44.33 514 490
2021-07-21 $43.49 $43.96 $42.37 $43.30 428 637
2021-07-20 $39.38 $43.54 $39.38 $43.45 806 009
2021-07-19 $39.83 $40.36 $37.88 $39.85 973 632
2021-07-16 $44.23 $44.62 $40.00 $40.64 1 564 996
2021-07-15 $42.78 $45.15 $42.63 $43.86 1 841 689
2021-07-14 $44.88 $46.42 $42.61 $43.71 5 114 346
2021-07-13 $42.32 $45.50 $40.94 $44.60 3 266 557
2021-07-12 $42.76 $45.39 $38.27 $40.67 6 546 173
2021-07-09 $31.04 $32.72 $30.75 $32.41 605 243
2021-07-08 $28.34 $31.17 $28.32 $31.04 831 262
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT